Medical Technologies IKC | 8
Directly
implanted
devices
Standard regenerative medicine involves
regenerating human cells and tissues;
what we’re doing is providing scaffolds,
made from acellular materials, that
patients’ own cells can grow into.
Developing
directly implanted
regenerative device
technologies is
absolutely central
to the mission of
the Medical
Technologies IKC.
Our researchers working in this
area are developing scaffolds,
biomaterials and devices
which enable tissue repair and
regeneration. We work closely
with our academic, industrial
and clinical partners to select
technologies with the highest
potential for commercialisation
and patient benefit.
Standard regenerative medicine
involves regenerating human cells
and tissues; what we’re doing is
providing scaffolds made from
acellular materials that patients’
own cells can grow into. This
potentially makes the regulatory
pathway more straightforward and
enables us to bring technologies
to market more quickly and cost
effectively.
Directly implanted devices make
up a large proportion of the
research funded by the Medical
Technologies IKC and we’ve seen
some great progress in a variety of
different applications.
In the past year, for example,
we’ve seen some of our
decellularised tendon devices
tested successfully in pre-clinical
trials and some really promising
proof of concept work in the area
of maxillofacial surgery.
Our pipeline of new projects is
now well established and we’re
looking forward to seeing these
develop further through the next
round of Medical Technologies
IKC funding.